Bayer will stop selling Essure Birth Control Implants
Bayer has announced it will stop selling their permanent birth control implant, Essure.
“This decision is based on a decline in U.S. sales of Essure in recent years and the conclusion that the Essure business is no longer sustainable,” Bayer said in a statement.
Bayer had already discontinued marketing and sales of Essure outside of the United States in September 2017.
Essure is made of two small coils that are placed into the fallopian tubes and is intended to cause inflammation and scar tissue that forms and blocks the tubes, preventing pregnancy.
From November 2002 to December 2017, the FDA received over 26,700 reports of serious and adverse side effects from the device. Common complaints are pain, headaches, pregnancy loss, and implant migration.
Earlier in the year, the Food and Drug Administration announced it would require Bayer to restrict sales of its Essure birth control to only medical practices and doctors that agreed to fully inform patients of the device’s risks and side effects. In 2016, the FDA ordered Essure to display a black box warning on the product. The black-box warning—the most severe warning issued by the FDA—will warn patients of adverse effects and the possibility of surgery if the device needs to be removed.
More than 16,000 lawsuits have been filed against Bayer, due to the pain and suffering that was caused by their Essure implant. They also allege Bayer had knowledge of the serious injuries Essure caused, but kept it on the market, and failed to properly warn patients. If you or a loved one has an Essure implant and has suffered serious side effects, please contact us at The Eichholz Law Firm. Our team of experienced Essure device attorneys can help.